Supplementary Data from ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors

The supplementary tables provide a list of antibodies, plasmids, and primer sets that were used throughout the study. They also include gene transcripts from RNA-Seq analysis that show the genomic pathways altered by the combination of PDI and HDAC inhibitors, as well as ATF3-dependent gene transcripts.